Maryland Capital Management Pure Bioscience, Inc. Transaction History
Maryland Capital Management
- $1.2 Billion
- Q3 2022
Shares
6 transactions
About PURE BIOSCIENCE, INC.
- Ticker PURE
- Exchange OTC
- Sector Consumer Defensive
- Industry Household & Personal Products
- Shares Outstandng 88,023,104
- Market Cap $7.92M
- Description
- PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual prot...